Skip to content
Surf Wiki
Save to docs
general/aminoethyl-compounds

From Surf Wiki (app.surf) — the open knowledge base

Triethylenetetramine


FieldValue
drug_nameTrientine
tradenameSyprine, Cuprior, Cufence, others
Drugs.com
DailyMedIDTrientine
ATC_prefixA16
ATC_suffixAX12
legal_AUS4
legal_AU_comment
legal_CARx-only
legal_CA_comment
legal_DE
legal_NZ
legal_UKPOM
legal_UK_comment
legal_USRx-only
legal_US_comment
legal_EURx-only
legal_EU_comment
legal_UN
legal_status
pregnancy_AUD
pregnancy_AU_comment
routes_of_administrationBy mouth
DrugBankDB06824
DrugBank2DBSALT001269
PDB_ligand104
IUPAC_name(2-aminoethyl)({2-[(2-aminoethyl)amino]ethyl})amine

N,''N'''-Bis(2-aminoethyl)ethane-1,2-diamine | TETA | trien | trientine (INN) | trientine dihydrochloride | MK-0681

Triethylenetetramine (TETA and trien), also known as trientine (INN) when used medically, is an organic compound with the formula [CH2NHCH2CH2NH2]2. The pure free base is a colorless oily liquid, but, like many amines, older samples assume a yellowish color due to impurities resulting from air oxidation. It is soluble in polar solvents. The branched isomer tris(2-aminoethyl)amine and piperazine derivatives may also be present in commercial samples of TETA. The hydrochloride salts are used medically as a treatment for copper toxicity.

Uses

Epoxy uses

The reactivity and uses of TETA are similar to those for the related polyamines ethylenediamine and diethylenetriamine. It is primarily used as a crosslinker ("hardener") in epoxy curing. TETA, like other aliphatic amines, react quicker and at lower temperatures than aromatic amines due to less negative steric effects since the linear nature of the molecule provides it the ability to rotate and twist.

Medical uses

| Drugs.com =

The hydrochloride salt of TETA, referred to as trientine hydrochloride, is a chelating agent that is used to bind and remove copper in the body to treat Wilson's disease, particularly in those who are intolerant to penicillamine. Some recommend trientine as first-line treatment, but experience with penicillamine is more extensive.

Trientine hydrochloride (brand name Syprine) was approved for medical use in the United States in November 1985.

Trientine tetrahydrochloride (brand name Cuprior) was approved for medical use in the European Union in September 2017. It is indicated for the treatment of Wilson's disease in adults, adolescents and children five years of age or older who are intolerant to D-penicillamine therapy.

Trientine dihydrochloride (brand name Cufence) was approved for medical use in the European Union in July 2019. It is indicated for the treatment of Wilson's disease in adults, adolescents and children five years of age or older who are intolerant to D-penicillamine therapy.

The most common side effects include nausea, especially when starting treatment, skin rash, duodenitis (inflammation of the duodenum, the part of the gut leading out of the stomach), and severe colitis (inflammation in the large bowel causing pain and diarrhea).

Society and culture

Controversies

In the United States, Valeant Pharmaceuticals International raised the price of its Syprine brand of TETA from $625 to $21,267 for 100 pills over five years. The New York Times said that this "egregious" price increase caused public outrage. Teva Pharmaceuticals developed a generic, which patients and doctors expected to be cheaper, but when it was introduced in February 2018, Teva's price was $18,375 for 100 pills. Aaron Kesselheim, who studies drug pricing at Harvard Medical School, said that drug companies price the product at what they think the market will bear.

Production

TETA is prepared by heating ethylenediamine or ethanolamine/ammonia mixtures over an oxide catalyst. This process gives a variety of amines, especially ethylene amines which are separated by distillation and sublimation. An idealized equation follows: :

Coordination chemistry

TETA is a tetradentate ligand in coordination chemistry, where it is referred to as trien. Octahedral complexes of the type M(trien)L2 can adopt several diastereomeric structures. 1,4,8,11-Tetraazaundecane is a closely related tetraamine ligand.

References

References

  1. (3 August 2022). "Health product highlights 2021: Annexes of products approved in 2021".
  2. (20 April 2021). "Regulatory Decision Summary for Waymade-Trientine".
  3. (2007). "Ethyleneamines". Huntsman.
  4. "Triethylenetetramine".
  5. (25 January 2021). "Trientine Waymade".
  6. (3 May 2021). "AusPAR: Trientine dihydrochloride".
  7. (23 October 2014). "Summary Basis of Decision (SBD) for Mar-Trientine".
  8. "Cuprior 150 mg film-coated tablets - Summary of Product Characteristics (SmPC)".
  9. "Trientine dihydrochloride Tillomed 250 mg capsules, hard - Summary of Product Characteristics (SmPC)".
  10. (22 December 2016). "Syprine- trientine hydrochloride capsule".
  11. (28 February 2020). "Trientine hydrochloride capsule".
  12. (20 May 2022). "Cuvrior- trientine tetrahydrochloride tablet, film coated".
  13. (February 2019). "A practice guideline on Wilson disease". Hepatology.
  14. (17 September 2018). "Cuprior EPAR".
  15. (24 May 2019). "Cufence EPAR".
  16. Thomas, Katie. (23 February 2018). "Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.".
  17. {{cite encyclopedia. (2005). Wiley-VCH
  18. (1999). "Plastics Materials". Butterworth-Heinemann.
  19. (1995). "Stereochemistry of Coordination Compounds". John Wiley.
  20. (1985). "Three Isomers of the ''trans''-Diammine-[''N'',''N''′-bis(2-Aminoethyl)-1,2-Ethanediamine]-Cobalt(III) Complex Cation".
Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about Triethylenetetramine — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report